Legacy Financial Advisors Inc. Grows Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Legacy Financial Advisors Inc. increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 11.4% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 2,325 shares of the medical equipment provider’s stock after purchasing an additional 237 shares during the quarter. Legacy Financial Advisors Inc.’s holdings in Intuitive Surgical were worth $1,214,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of ISRG. Scotia Capital Inc. raised its holdings in Intuitive Surgical by 4.1% during the fourth quarter. Scotia Capital Inc. now owns 5,166 shares of the medical equipment provider’s stock valued at $2,697,000 after acquiring an additional 204 shares during the period. F M Investments LLC raised its holdings in Intuitive Surgical by 8.6% during the fourth quarter. F M Investments LLC now owns 20,426 shares of the medical equipment provider’s stock valued at $10,662,000 after acquiring an additional 1,611 shares during the period. DRW Securities LLC raised its holdings in Intuitive Surgical by 47.0% during the fourth quarter. DRW Securities LLC now owns 2,205 shares of the medical equipment provider’s stock valued at $1,151,000 after acquiring an additional 705 shares during the period. APG Asset Management US Inc. bought a new stake in Intuitive Surgical during the fourth quarter valued at about $3,833,000. Finally, Azimuth Capital Investment Management LLC raised its holdings in Intuitive Surgical by 6.9% during the fourth quarter. Azimuth Capital Investment Management LLC now owns 42,232 shares of the medical equipment provider’s stock valued at $22,043,000 after acquiring an additional 2,713 shares during the period. 83.64% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

ISRG has been the topic of several research reports. Raymond James lifted their target price on Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. Barclays lifted their target price on Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. Robert W. Baird reduced their target price on Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating on the stock in a report on Tuesday, March 18th. Citigroup lifted their target price on Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a report on Friday, January 24th. Finally, Royal Bank of Canada lifted their price target on Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $611.86.

Intuitive Surgical Stock Up 14.3 %

Shares of NASDAQ:ISRG opened at $522.95 on Thursday. The company has a market capitalization of $186.26 billion, a price-to-earnings ratio of 81.58, a price-to-earnings-growth ratio of 5.85 and a beta of 1.55. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00. The firm has a 50 day moving average of $536.22 and a 200 day moving average of $532.26.

Insider Buying and Selling

In other news, EVP Myriam Curet sold 408 shares of the business’s stock in a transaction on Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total transaction of $240,618.00. Following the sale, the executive vice president now directly owns 353 shares of the company’s stock, valued at $208,181.75. The trade was a 53.61 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Jamie Samath sold 94 shares of the business’s stock in a transaction on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total transaction of $53,684.34. Following the sale, the chief financial officer now directly owns 2,630 shares in the company, valued at $1,502,019.30. This trade represents a 3.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 33,754 shares of company stock valued at $17,691,621 over the last 90 days. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.